DelSiTech, Bayer partner for ophthalmology

Thursday, October 6, 2016

DelSiTech, a Finnish drug delivery technology and drug development company, and Bayer have signed a collaboration and technology license agreement for the worldwide application of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology. 

[Read More]